PDUFA VIII: US FDA Willing To Risk One-Time Potential Revenue Reduction In Five-Year Cycle

 
• By Derrick Gingery
  
The FDA could see a one-time PDUFA revenue reduction under a proposal for the upcoming program cycle. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from User Fees

More from United States